tiprankstipranks
Advertisement
Advertisement

DE:UG2 Stock Latest News

AngioDynamics announces two-year PRESERVE trial data
The FlyAngioDynamics announces two-year PRESERVE trial data
23d ago
ANGO
AngioDynamics Files Patent Suit to Protect Thrombectomy Technology
PremiumCompany Announcements
AngioDynamics Files Patent Suit to Protect Thrombectomy Technology
1M ago
8K
ANGO
AngioDynamics initiated with a Buy at Freedom Broker
PremiumThe Fly
AngioDynamics initiated with a Buy at Freedom Broker
2M ago
ANGO
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
PremiumRatings
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
2M ago
ANGO
AngioDynamics price target lowered to $16 from $18 at Canaccord
PremiumThe Fly
AngioDynamics price target lowered to $16 from $18 at Canaccord
2M ago
ANGO
AngioDynamics Earnings Call Highlights Med Tech Momentum
PremiumCompany AnnouncementsAngioDynamics Earnings Call Highlights Med Tech Momentum
2M ago
ANGO
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
Premium
The Fly
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
2M ago
F
BP
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance
Premium
Company Announcements
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance
2M ago
8K
ANGO
AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
PremiumThe Fly
AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
2M ago
ANGO
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
PremiumThe Fly
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
2M ago
ANGO
AngioDynamics announces CEO transition and leadership retention plan
PremiumCompany Announcements
AngioDynamics announces CEO transition and leadership retention plan
4M ago
8K
ANGO
AngioDynamics Highlights Growth Strategy at J.P. Morgan Conference
PremiumCompany Announcements
AngioDynamics Highlights Growth Strategy at J.P. Morgan Conference
5M ago
8K
ANGO
AngioDynamics: Operational Outperformance, Raised FY2026 Outlook, and Advancing Clinical Pipeline Support Buy Rating and $16 Target
PremiumRatingsAngioDynamics: Operational Outperformance, Raised FY2026 Outlook, and Advancing Clinical Pipeline Support Buy Rating and $16 Target
5M ago
ANGO
AngioDynamics Earnings Call Highlights Med Tech Momentum
Premium
Company Announcements
AngioDynamics Earnings Call Highlights Med Tech Momentum
5M ago
ANGO
Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix
Premium
The Fly
Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix
5M ago
E
ET
AngioDynamics posts strong Q2 results, raises 2026 outlook
PremiumCompany Announcements
AngioDynamics posts strong Q2 results, raises 2026 outlook
5M ago
8K
ANGO
AngioDynamics says still expects to be cash flow positive for FY26
PremiumThe Fly
AngioDynamics says still expects to be cash flow positive for FY26
5M ago
ANGO
AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)
PremiumThe Fly
AngioDynamics reports Q2 adjusted EPS 0c, consensus (10c)
5M ago
ANGO
AngioDynamics backs FY26 adjusted EPS view (33c)-(23c), consensus (33c)
PremiumThe Fly
AngioDynamics backs FY26 adjusted EPS view (33c)-(23c), consensus (33c)
5M ago
ANGO
AngioDynamics says Jim Clemmer to retire during FY27 as CEO
PremiumThe FlyAngioDynamics says Jim Clemmer to retire during FY27 as CEO
5M ago
ANGO
ANGO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ANGO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
ANGO
Midday Fly By: Tesla reports deliveries, Trump delays furniture tariff hike
Premium
The Fly
Midday Fly By: Tesla reports deliveries, Trump delays furniture tariff hike
5M ago
W
RH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >